Live or let die: the cell's response to p53

Karen H. Vousden,Xin Lu

DOI: https://doi.org/10.1038/nrc864

IF: 78.5

2002-08-01

Nature Reviews Cancer

Abstract:Key Points p53 is a tumour-suppressor protein that induces apoptotic cell death in response to oncogenic stress. Malignant progression is dependent on loss of p53 function, either through mutation in the TP53 gene (which encodes p53) itself or by defects in the signalling pathways that are upstream or downstream of p53. Mutations in TP53 occur in about half of all human cancers, almost always resulting in the expression of a mutant p53 protein that has acquired transforming activity. p53-induced apoptosis depends on the ability of p53 to activate gene expression, although transcriptionally independent activities of p53 can also contribute to the apoptotic response. The apoptotic and cell-cycle arrest activities of p53 can be separated, and apoptotic cofactors that play a specific role in allowing p53-induced death are being identified. Regulation of the apoptotic function of p53 is associated with selective activation of apoptotic target genes. Cofactors that specifically contribute to p53-mediated activation of apoptotic target genes include JMY, ASPP and the other p53-family members p63 and p73. Phosphorylation of p53 regulates its ability to activate the expression of apoptotic target genes, and other post-translational modifications such as acetylation might also have a role. In tumours that retain wild-type p53, the apoptotic response might be hindered by defects in the apoptotic cofactors. These, therefore, represent additional targets for the design of therapeutics that are aimed at reactivating p53-mediated apoptosis in cancer cells.

oncology